Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gut Microbiota in NSCLC Brain Metastasis Treated with Pembrolizumab + Chemotherapy
NCT04333004Phase 2Unknown
- Start
- Apr 2020
- Primary completion
- Apr 2021
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of pembrolizumab in non-small cell lung cancer (NSCLC). Status: unknown.
02
Drugs
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT04333004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04333004.